insurance coverage for glp 1 medications The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Upcoming Insurance Changes for GLP-1

Description

Frontiers in Cell and Developmental Biology

Novo Nordisk, a Danish pharmaceutical giant, launched its once-weekly injectable weight-loss medicine Wegovy, a blockbuster drug, on June 24

it reflects our core belief that effective weight care should be accessible to everyone who needs itWeve seen that without insurance coverage, the majority of patients may discontinue treatment due to cost barriers. By working within the healthcare system rather than around it, were creating sustainable, long-term access to quality care while challenging the persistent stigma that frames weight management as a lifestyle choice rather than a medical need, explains Dr

As mentioned, a secondary analysis of an RCT assessing the cardiometabolic effects of exenatide in 40 people with schizophrenia 140 also looked at measures of cognition and psychosocial functioning (that is, Brief Assessment of Cognition in Schizophrenia, ReyOsterreith Complex Figure Test, Short-Form Health Survey, Personal and Social Performance Scale, Positive and Negative Syndrome Scale), but found no effect for this GLP-1RA compared with placebo over 3 months 133